Plain-English translation of NCT06148935 on ClinicalTrials.gov ↗ ·
This is a real-world study of Vericiguat, a medication already approved to help people whose hearts don't pump blood well. Researchers will collect information from your regular doctor visits over about a year to learn how safe this medication is and how well it works in Korean patients with heart failure.
Even though this medication has been studied before and is available from doctors, gathering information from actual patients in Korea will help doctors understand how the treatment performs in everyday practice and catch any safety concerns early.
You likely qualify if…
You likely don't qualify if…
You will continue taking the medication exactly as your doctor prescribes it as part of your regular heart failure care. Researchers will collect information from your normal doctor visits and medical records for up to 12 months, tracking any side effects, hospital visits, and how well the medication is working. You won't need to do anything extra beyond your regular appointments—the study simply documents what's already happening in your care.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
South Korea